UBS challenges lithium market pessimism, arguing bears overlook spodumene feedstock constraints while refining capacity outpaces mine supply, lifting shares of Liontown and Albemarle (NYSE: ALB).

Key Highlights

  • UBS maintains an overweight stance on lithium, citing a structural mismatch where refining capacity exceeds spodumene mine output.
  • Wood Mackenzie’s bearish view focuses on tonnage metrics, ignoring the binding constraint of hard-rock feedstock availability.
  • CATL’s delayed lepidolite mine restart could remove 40,000 tonnes of lithium carbonate equivalent from the market in late 2026.
  • UBS rates Liontown, Albemarle (NYSE: ALB), and Mineral Resources as Buys.

Analysts at UBS argue that spodumene, the hard-rock feedstock for lithium refining, is the true bottleneck, not total tonnage. While refining capacity in China expands rapidly, mine projects lag due to longer lead times and offtake agreements. This structural imbalance keeps feedstock tight, regardless of broader supply projections.

Energy storage demand remains resilient, and battery exports continue to grow, offsetting domestic EV saturation concerns. The market’s recent pullback in GFEX futures reflects a misreading of installation data, not a collapse in consumption. This timeline is expected to pull demand forward, creating a temporary surge followed by a sharp drop-off.

The effect could tighten spot markets before the cliff arrives. CATL’s lepidolite project, currently offline, is projected to add 40,000 tonnes of lithium carbonate equivalent if it comes back online in the second half of 2026. Any delay would deepen feedstock scarcity, reinforcing UBS’s bullish thesis.

The market’s failure to price this risk leaves bears exposed to sudden tightness. Spodumene mines cannot scale as quickly as chemical plants, leaving refiners dependent on a limited pool of feedstock. Wood Mackenzie’s bear case, built on tonnage forecasts, ignores this imbalance.

Investor Insights

UBS’s analysis suggests the market is grading lithium on the wrong metric. Investors should watch CATL’s lepidolite timeline and China’s rebate phase-out for near-term catalysts. Stocks like Liontown and Albemarle (NYSE: ALB) stand to benefit if the market corrects its mispricing of supply chain dynamics.

This article is for informational purposes only and does not constitute financial advice. Please consult a licensed financial adviser before making investment decisions.